Alkyl Amines Chemicals Ltd. Q1 FY27 Financials and Leadership Update

Alkyl Amines Chemicals Ltd. has announced its financial results for the first quarter of Fiscal Year 2027 (Q1 FY27), reporting a substantial increase in revenue and profit. The company's standalone revenue for the quarter ended June 30, 2026, stood at ₹528.01 crore.

Profit After Tax (PAT) for the same period reached ₹94.63 crore, a significant jump from ₹45.37 crore in the previous quarter (Q4 FY26) and ₹49.44 crore in the corresponding quarter of the previous year (Q1 FY26). Basic Earnings Per Share (EPS) rose to ₹18.50.

Reader Takeaway: Strong profit growth driven by higher revenue; governance watch point remains litigation.

What just happened

Alkyl Amines Chemicals Ltd. reported its Q1 FY27 financial results, showing a standalone revenue of ₹528.01 crore and a Profit After Tax (PAT) of ₹94.63 crore. This represents a significant year-on-year increase in both top-line and bottom-line figures. The company also announced several management re-designations, including Mr. Yogesh M. Kothari as Executive Chairman, and Mr. Kirat M. Patel and Mr. Suneet Y. Kothari as Joint Managing Directors. Additionally, Mr. Rakesh Goyal was appointed as Executive Director - Operations.

Why this matters

These strong financial results indicate robust operational performance and increasing demand for Alkyl Amines' products. The PAT surge, in particular, suggests improved profitability and efficiency. The leadership changes signal a structured approach to succession planning and operational continuity, which is crucial for sustained growth. However, the ongoing legal proceedings involving an Executive Director are a governance concern that investors will watch.

The backstory

In the previous quarter (Q4 FY26), Alkyl Amines Chemicals reported revenue of ₹386.91 crore and PAT of ₹45.37 crore. For the prior year's comparable quarter (Q1 FY26), revenue was ₹405.53 crore and PAT was ₹49.44 crore. The current results demonstrate a clear acceleration in growth momentum across revenue and profitability.

What changes now

With these strong Q1 FY27 results, the company is poised for continued growth. The approved leadership changes, once ratified by shareholders, will formalize the management structure and succession pipeline. The approval for commission payments to Non-Executive Directors, also pending shareholder consent, will align their interests with company performance over the next five years.

Risks to watch

A key concern highlighted is the ongoing criminal and civil litigation against Executive Director Mr. Rakesh Goyal, filed by National Peroxide Limited. While the matter is sub-judice, it represents a governance risk and potential reputational issue for the company.

Peer comparison

While the filing does not provide peer comparison, Alkyl Amines operates in the specialty chemicals sector, which has seen mixed performance. Companies in this segment are often evaluated on revenue growth, EBITDA margins, and return ratios. The strong Q1 FY27 performance positions Alkyl Amines favorably among its peers, provided the growth is sustainable.

Context metrics (time-bound)

• Q1 FY27 Revenue: ₹528.01 Cr (vs ₹386.91 Cr in Q4 FY26, vs ₹405.53 Cr in Q1 FY26)
• Q1 FY27 PAT: ₹94.63 Cr (vs ₹45.37 Cr in Q4 FY26, vs ₹49.44 Cr in Q1 FY26)
• Q1 FY27 Basic EPS: ₹18.50 (vs ₹8.87 in Q4 FY26, vs ₹9.67 in Q1 FY26)
• Total Expenses Q1 FY27: ₹412.64 Cr (vs ₹334.40 Cr in Q4 FY26)

What to track next

Investors will be keen to see how the company sustains this growth trajectory in the upcoming quarters. Monitoring the progress and outcome of the legal case against Mr. Rakesh Goyal, and the shareholder approval for management changes and commission payments will be crucial.